Purple Biotech Statistics

Total Valuation

Purple Biotech has a market cap or net worth of ILS 32.54 million. The enterprise value is 10.16 million.

Market Cap	32.54M
Enterprise Value	10.16M

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Purple Biotech has 516.55 million shares outstanding. The number of shares has increased by 9.34% in one year.

Current Share Class	n/a
Shares Outstanding	516.55M
Shares Change (YoY)	+9.34%
Shares Change (QoQ)	-99.37%
Owned by Insiders (%)	0.46%
Owned by Institutions (%)	0.50%
Float	457.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.00
P/TBV Ratio	5.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.23
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.01.

Current Ratio	1.27
Quick Ratio	1.15
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-29.08

Financial Efficiency

Return on equity (ROE) is -34.39% and return on invested capital (ROIC) is -29.18%.

Return on Equity (ROE)	-34.39%
Return on Assets (ROA)	-24.97%
Return on Capital (ROIC)	-29.18%
Revenue Per Employee	n/a
Profits Per Employee	-2.17M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.71% in the last 52 weeks. The beta is 0.29, so Purple Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-79.71%
50-Day Moving Average	6.61
200-Day Moving Average	16.13
Relative Strength Index (RSI)	44.13
Average Volume (20 Days)	9,108,218

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-728,591
Operating Income	-59.68M
Pretax Income	-43.58M
Net Income	-43.34M
EBITDA	-59.52M
EBIT	-59.68M
Earnings Per Share (EPS)	-0.20

Full Income Statement

Balance Sheet

The company has 23.42 million in cash and 825,241 in debt, giving a net cash position of 22.59 million or 0.04 per share.

Cash & Cash Equivalents	23.42M
Total Debt	825,241
Net Cash	22.59M
Net Cash Per Share	0.04
Equity (Book Value)	109.54M
Book Value Per Share	63.10
Working Capital	5.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-64.44M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.34%
Shareholder Yield	-9.34%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on January 6, 2019. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 6, 2019
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a